← Back to Search

Behavioral Intervention

Peer Education for HIV Prevention

N/A

Recruiting

Led By Heather A Pines, PhD

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Sexual activity with cisgender men or transgender women in their lifetime

Cisgender male

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-month follow-up

Awards & highlights

Study Summary

This trial will test a program to train young Latino and Black men who have sex with men to promote PrEP use among HIV-negative YMSM of color in their social networks.

Who is the study for?

This trial is for young Latino or Black men who have sex with men (YMSM), aged 18-34, living with HIV or using PrEP. Participants must be willing to share their status and promote PrEP within their social networks of similar peers.Check my eligibility

What is being tested?

The OPPEN program trains YMSM of color either living with HIV or on PrEP to educate their peers about using PrEP. This study will assess how well the program works and if it's easy to implement among these communities.See study design

What are the potential side effects?

Since this trial focuses on education and peer-driven intervention rather than a medical treatment, there are no direct side effects from drugs; however, participants may experience social or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have had sexual relations with cisgender men or transgender women.

Select...

I am a cisgender male.

Select...

I am between 18 and 34 years old.

Select...

I am not taking medication to prevent HIV.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

PrEP interest

PrEP linkage

PrEP uptake

Secondary outcome measures

OPPEN acceptability

OPPEN feasibility

PrEP behavioral skills

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: OPPEN InterventionExperimental Treatment1 Intervention

OPPEN consists of three small-group and two one-on-one sessions to train YMSM of color engaged in HIV or PrEP care to be peer PrEP educators within their social networks.

Group II: Control ConditionExperimental Treatment1 Intervention

The time- and attention-matched control condition consists of three small-group and two one-on-one sessions to support diet and nutrition behavior change.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Control Condition

2008

Completed Phase 3

~18610

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor

1,121 Previous Clinical Trials

1,521,215 Total Patients Enrolled

Heather A Pines, PhDPrincipal InvestigatorUniversity of California, San Diego

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings in this investigation for participants?

"According to the clinicaltrials.gov portal, this medical trial is still accepting participants and remains current after its initial posting on April 7th 2022 and subsequent updates done by April 26th of that year."

Answered by AI

What is the overall aim of this experiment?

"The primary outcome that is monitored over the three-month follow up period of this trial, concerns Prep interest. Secondary objectives being measured are Self-reported surveys about conversations with peers and knowledge about PrEP alongside behavioural skills related to it."

Answered by AI

Does this experiment include individuals aged 45 or older?

"This medical study is seeking participants aged between 18 and 29 years old."

Answered by AI

What is the projected enrollment size for this clinical trial?

"Indeed. According to clinicaltrials.gov, the trial which first appeared on April 7th 2022 is still recruiting participants. 210 individuals need be sourced from a single healthcare facility for this investigation."

Answered by AI

Am I eligible to partake in this research endeavor?

"This medical trial is admitting 210 individuals who are HIV-positive and between 18 to 29 years old. To qualify, candidates must be cisgender male, understand English or Spanish fluently, identify as Latino or Black, involved in HIV care or Prep use, have sexual relations with either cisgender males or transgender women at least once before in their lifetime, connected to a social network of three 18-29 year-old peers of color that they’re willing to disclose their HIV status/PrEP usage too , consenting via written informed agreement, and not currently using PrEP."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Onboarding Positives and PrEP Users to Engage Negatives (OPPEN): Peer-driven Education to Link YMSM of Color to PrEP

Heather Pines 2022. "Onboarding Positives and PrEP Users to Engage Negatives (OPPEN): Peer-driven Education to Link YMSM of Color to PrEP". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05356910.

All > Mens Health